DHA-Paclitaxel (Taxoprexin) as First-Line Treatment in Patients with Stage IIIB or IV Non-small Cell Lung Cancer: Report of a Phase II Open-Label Multicenter Trial

2006 ◽  
Vol 1 (9) ◽  
pp. 984-990 ◽  
Author(s):  
Miranda Payne ◽  
Paul Ellis ◽  
David Dunlop ◽  
Malcolm Ranson ◽  
Sarah Danson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Multicenter Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Open Label ◽  
First Line Treatment

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

1997 ◽  
Vol 33 ◽  
pp. S236 ◽  
Author(s):  
N. Androulakis ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
A.M. Dimopoulos ◽  
E. Papadakis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document